机译:供体来源CAR19 T细胞输注B-全部在同种异体造血干细胞移植后复发
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
East China Normal Univ Sch Chem &
Mol Engn Shanghai Peoples R China;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
East China Normal Univ Sch Chem &
Mol Engn Shanghai Peoples R China;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
Soochow Univ Affiliated Hosp 1 Natl Clin Res Ctr Hematol Dis Jiangsu Inst Hematol Suzhou;
机译:供体来源CAR19 T细胞输注B-全部在同种异体造血干细胞移植后复发
机译:供体衍生的抗CD19 Car T细胞与因同种异体造血干细胞移植后反复化B-全部的供体淋巴细胞输注相比。
机译:异基因造血干细胞移植后复发性血液系统癌患者先后顺序注入供体来源的树突状细胞和供体淋巴细胞
机译:循环肿瘤DNA预测AML和MDS中的同种异体造血干细胞移植
机译:接受同种异体造血干细胞移植的患者的供体选择:加拿大造血干细胞移植医生的优先事项评估。
机译:异基因造血干细胞移植治疗慢性粒细胞白血病后分子复发后早期给予供体淋巴细胞输注:EBMT慢性恶性肿瘤工作组的研究
机译:供体淋巴细胞输注治疗异基因造血干细胞移植后复发的急性髓样白血病:日本造血细胞移植学会成人急性髓样白血病工作组的回顾性分析